GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integrum AB (OSTO:INTEG B) » Definitions » EBIT

Integrum AB (OSTO:INTEG B) EBIT : kr-5.08 Mil (TTM As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Integrum AB EBIT?

Integrum AB's earnings before interest and taxes (EBIT) for the three months ended in Jan. 2024 was kr0.42 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jan. 2024 was kr-5.08 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Integrum AB's annualized ROC % for the quarter that ended in Jan. 2024 was 53.72%. Integrum AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was 4.36%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Integrum AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was -0.51%.


Integrum AB EBIT Historical Data

The historical data trend for Integrum AB's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrum AB EBIT Chart

Integrum AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
EBIT
Get a 7-Day Free Trial Premium Member Only -24.40 -15.46 -2.06 1.20 -21.51

Integrum AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.77 -9.04 -2.93 6.46 0.42

Competitive Comparison of Integrum AB's EBIT

For the Medical Devices subindustry, Integrum AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integrum AB's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integrum AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Integrum AB's EV-to-EBIT falls into.



Integrum AB EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-5.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Integrum AB  (OSTO:INTEG B) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Integrum AB's annualized ROC % for the quarter that ended in Jan. 2024 is calculated as:

ROC % (Q: Jan. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Oct. 2023 ) + Invested Capital (Q: Jan. 2024 ))/ count )
=24.32 * ( 1 - -177.38% )/( (121.394 + 129.755)/ 2 )
=67.458816/125.5745
=53.72 %

where

Note: The Operating Income data used here is four times the quarterly (Jan. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Integrum AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jan. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Oct. 2023  Q: Jan. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1.692/( ( (7.692 + max(30.021, 0)) + (7.228 + max(32.641, 0)) )/ 2 )
=1.692/( ( 37.713 + 39.869 )/ 2 )
=1.692/38.791
=4.36 %

where Working Capital is:

Working Capital(Q: Oct. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(25.813 + 20.688 + 0.788) - (7.205 + 0 + 10.063)
=30.021

Working Capital(Q: Jan. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(29.24 + 21.523 + 0.84099999999999) - (8.059 + 0 + 10.904)
=32.641

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jan. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Integrum AB's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jan. 2024 )
=-5.082/988.373
=-0.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Integrum AB EBIT Related Terms

Thank you for viewing the detailed overview of Integrum AB's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Integrum AB (OSTO:INTEG B) Business Description

Traded in Other Exchanges
Address
Krokslatts Fabriker 50, Molndal, SWE, SE-431 37
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.

Integrum AB (OSTO:INTEG B) Headlines

No Headlines